| Wendell Yarbrough, MD | |
|
35 Park Street, Smilow Cancer Hospital, New Haven, CT 06511 | |
| (203) 200-4622 | |
| Not Available |
| Full Name | Wendell Yarbrough |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 35 Years |
| Location | 35 Park Street, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457448565 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD37330 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of North Carolina Hospital | Chapel hill, NC | Hospital |
| Rex Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians And Associates | 0648181156 | 1656 |
News Archive
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
Researchers in Australia have discovered that gonorrhea, which is considered to be a sexually transmitted disease, may actually be spread by oral sex and even kissing.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
An in-depth analysis of more than 20,000 health related mobile applications (mHealth apps) published by The BMJ today finds "serious problems with privacy and inconsistent privacy practices."
New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.
› Verified 3 days ago
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
Researchers in Australia have discovered that gonorrhea, which is considered to be a sexually transmitted disease, may actually be spread by oral sex and even kissing.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
An in-depth analysis of more than 20,000 health related mobile applications (mHealth apps) published by The BMJ today finds "serious problems with privacy and inconsistent privacy practices."
New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendell Yarbrough, MD 800 Howard Avenue, Yale Physicians Building, 4th Floor, New Haven, CT 06519 Ph: (203) 200-4622 | Wendell Yarbrough, MD 35 Park Street, Smilow Cancer Hospital, New Haven, CT 06511 Ph: (203) 200-4622 |
News Archive
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
Researchers in Australia have discovered that gonorrhea, which is considered to be a sexually transmitted disease, may actually be spread by oral sex and even kissing.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
An in-depth analysis of more than 20,000 health related mobile applications (mHealth apps) published by The BMJ today finds "serious problems with privacy and inconsistent privacy practices."
New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.
› Verified 3 days ago
Dr. Kiley Edward Trott, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Park Street, Wing West Pavilion Fl 2nd Floor, New Haven, CT 06504 Phone: 203-785-5430 Fax: 203-785-3970 | |
Mark S Bianchi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 55 Lock Street, New Haven, CT 06511 Phone: 203-375-0050 Fax: 203-380-1616 | |
Dr. Sara Isabel Pai, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Park St, New Haven, CT 06519 Phone: 855-476-4569 | |
Dr. Richard Peter Manes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-3970 | |
Sam D Schild, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 330 Cedar Street, New Haven, CT 06510 Phone: 203-785-5430 | |
Mark A Dagostino, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-776-1288 Fax: 203-776-7741 | |
Ken Yanagisawa, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-787-4244 Fax: 203-776-7741 |